 LEXINGTON, Mass., Jan. 20, 2021 GLOBE NEWSWIRE -- Kaleido Biosciences, Inc. Nasdaq: KLDO, today announced Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer, will present at the Keystone Symposium Harnessing the Microbiome for Disease Prevention and Therapy conference this afternoon at 12:15 p.m. MST. The presentation will provide an update on progress with the Kaleido MMTTM platform, including a review of the K031 COVID-19 study interim data that were announced on January 14, 2021. 